Professional Documents
Culture Documents
Presentor
Joyce Acena, RN, MAN
GOAL: Understand foundational concepts relevant to
pharmacology
Pharmacopeia
Source: Wiggins, J.M. and Albanese, J.A. (2019), A Brief History of Pharmacopeias: A Global
Perspective, Pharmacopeia Compliance Series
The official book of the standards and
Series 2004)
COMMON TERMINOLOGIES USED
1 2 3 4
Companies,
organizations and
individuals who
wish to introduce
new medications in
any country should
undergo clinical
trial under the
supervision,
monitoring, review
and approval of a
regulatory
commission of the
country where it is
to be used.
CLASS 3 According to
PREGNANCY
CATEGORY
1+2+3 BODY SYSTEMS
DRUG CLASSIFICATIONS
Classification EXAMPLES
According to BODY SYSTEMS CNS drugs, Cardiovascular drugs,
Respiratory drugs, Kidney drugs
Animal studies have not demonstrated a risk to the fetus but there are no
Pregnancy adequate studies in pregnant human, OR;
Category B
Animal studies have shown an adverse effect, but adequate studies in
pregnant humans have not demonstrated a risk to the fetus in the first
trimester of pregnancy, and no evidence of risk in late trimester
Examples include certain antibiotics such Amoxicillin and Penicillin
Pregnancy Category
CATEGORY DESCRIPTION
Pregnancy Animal studies have shown an adverse effect on the fetus but there are
Category C no adequate studies in humans; the benefits from the use of the drug in
pregnant women maybe acceptable despite its potential risks
Examples include Aspirin, Fluoroquinoles, Gentamicin
Pregnancy There is evidence of human fetal risk, but the potential benefits from the
Category D use of the drug in pregnant women may be acceptable despite its
potential risks
Examples include Tetracyclines, Chemotherapy drugs, ACE inhibitors
Pregnancy Category
CATEGORY DESCRIPTION
Pregnancy Teratogenic. Evidence of fetal harm is established. May cause congenital
Category X disease or death of the fetus.
Example includes contraceptive drugs
Substance Abuse Category
CATEGORY DESCRIPTION
Classification I Drugs or substances that have a high potential for abuse; no
Schedule 1 (S1) currently accepted medical use and have a lack of accepted safety
for use under medical supervision. (heroin, marijuana)
Classification II Drugs or substances that have a high potential for abuse; currently
Schedule 2 (S2) : have an accepted medical use in treatment but with severe
(Yellow prescription restrictions; abuse may lead to severe psychological or physical
drugs) dependence. (narcotics, amphetamines, barbiturates). purchaser
must be at least 18 years old, and all transactions must be recorded
by the dispensing pharmacist.
Substance Abuse Category
CATEGORY DESCRIPTION
Classification III Drugs or substances that have a potential for abuse less than
Schedule 3 (S3) : Schedule I or II; currently have an accepted medical use; abuse may
lead to moderate or low physical and high psychological dependence.
(some sedatives, anti-anxiety and non-narcotic analgesics)
Classification IV Drugs or substances that have a low potential for abuse relative to
Schedule 4 (S4) : those listed in Schedule III; currently have an accepted medical use;
abuse may lead to limited physical or psychological dependence those
in schedule III.
Classification V Drugs or substances that have a low potential for abuse relative to
Schedule 5 (S5): Schedule IV; may not need prescription by a doctor (Over-the-Counter
or OTC drugs).